| 000 | 01348 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516211151.0 | ||
| 264 | 0 | _c20140812 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a0392-856X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Herwaarden, N | |
| 245 | 0 | 0 |
_aDose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity. _h[electronic resource] |
| 260 |
_bClinical and experimental rheumatology _c |
||
| 300 |
_a390-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHerfkens-Hol, S | |
| 700 | 1 | _avan der Maas, A | |
| 700 | 1 | _avan den Bemt, B J F | |
| 700 | 1 | _avan Vollenhoven, R F | |
| 700 | 1 | _aBijlsma, J W J | |
| 700 | 1 | _aden Broeder, A A | |
| 773 | 0 |
_tClinical and experimental rheumatology _gvol. 32 _gno. 3 _gp. 390-4 |
|
| 999 |
_c23776149 _d23776149 |
||